- Con la presencia del ICE, habitantes de Minnesota crearon un sistema médico en las sombras. Un aprendizaje para otras ciudades
- As ICE Moved In, Minnesotans Set Up a Shadow Medical System. It’s a Lesson for Other Cities.
- Trump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at Home
- Listen: What To Do When Health Insurance Slips Out of Reach
- Essentia Health shifts recreational therapists to tech roles; union protests changes
- Texas oral surgery practice opens 2 locations
- Intermountain cuts charting time 27% with AI assistant
- How 3 insurers are trying to tighten E/M billing oversight
- How 3 insurers are trying to tighten E/M billing oversight
- Texas orthodontics practices merge
- 73% of VA healthcare roles cut were recently filled: New York Times
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Children’s Health taps chief investment officer
- Appeals court could revive cardiologist’s anti-DEI retaliation lawsuit
- Mistrial declared in Virginia unlicensed dentistry case
- GI cancers to double by 2050: Report
- Private equity’s growing influence in healthcare — 6 recent deals
- Beth Israel Lahey Health CEO to step down next year
- 10 health systems named ‘exceptional workplaces’: Gallup
- Allegheny Health Network taps UH exec as chief nurse
- What It Takes to Deploy AI at Scale in Dentistry—and Why It Matters
- California system moves to delay layoffs
- California system moves to delay layoffs
- Why Prisma Health is betting big on outpatient expansion
- Anesthesia reimbursement decline over the last 5 years
- Federal resolution introduced to back fluoride use
- Salt Dental Partners expands in 3 states
- Cardiology and private equity in 2026: 5 notes
- UPMC gifted $1.25M to support care in North Central Pennsylvania
- NYC Health + Hospitals advances behavioral health strategy: 4 things to know
- Opening Remarks at Private Markets Roundtable
- 2 ASC consulting firms partner on united platform
- Strategic Radiology adds 14-physician practice
- 50 anesthesiology departments ranked by NIH funding
- Rhode Island lawmaker pushes for creation of new dental school: 6 notes
- Hospitals decry drugmakers' expanded claims reporting policies for 340B
- CMS releases toolkit for children’s behavioral health services
- Qventus Launches Care Gap and Coding Automation Suite to Improve Patient Care and Reimbursement Revenue
- $32M deal closes on Boston-area medical center
- Dental therapist bill fails in Florida Senate
- ECU Health opens 2 gastroenterology clinics following practice acquisition
- Straine Dental Management adds 6th Texas practice
- Newport Healthcare taps chief growth and experience officer
- Independent autism research committee forms amid concerns over federal panel
- 12 health systems seeking revenue cycle vice presidents
- CommonSpirit eyes ASC growth to diversify portfolio
- From -2.6% to 10.7%: How 12 academic systems’ margins compare
- Remarks at Financial Stability Oversight Council Artificial Intelligence Innovation Series Roundtable on Strategy and Governance Principles
- Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
- Review of U.S. Measles Elimination Status Delayed Until November
- Your Furry Roommate May Be Affecting The Air You Breathe
- BioDuro enters Taiwan joint venture, adding commercial API plant to production network
- FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid
- MUSC Health acquires South Carolina's largest multispecialty practice for $111M
- Beth Israel Lahey Health back in the black in Q1
- About 81,000 Baby Monitors Recalled Over Possible Fire Risk
- Armed with funding and an acquisition, Procode AI launches AI-powered RCM for surgical billing
- Charities merge to form nation's 'most comprehensive' patient assistance nonprofit
- Two Days of Oatmeal May Lower Cholesterol, Study Finds
- Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia
- Colorectal Cancer Rates Shifting to Younger Groups as Rectal Cancer Rates Spike
- Brain Chemical Provides A 'Pep In Your Step,' Experiment Shows
- Lithium Might Slow Brain Decline Among Seniors, Pilot Study Shows
- Exercise Boosts Quality of Life During Breast Cancer Chemotherapy
- Early Sports Specialization Linked To Increased Injury Risk
- More Kids, Teens Injured In E-Bike Wrecks, Study Finds
- Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
- Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus
- Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
- Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
- Healthcare’s mixed Q4, plus insights from the Lake Nona Impact Forum
- Danish agency NoA Health names new CEO to drive global expansion
- Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
- Bassett Healthcare Network appoints division chief of dental services
- Aetna fined $550K for mental health parity violations
- Why CommonSpirit is exiting Conifer
- California provider opens teen mental health center
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- HCA Healthcare says all-time high inpatient occupancy, ACA exchange attrition won't spoil 2026 volume growth
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'
- Ireland’s biopharma appeal holds up amid unsteady geopolitical backdrop, US investment blitz
- Papa rolls out new program for insurers called Papa Plus
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Rising Stars: Boehringer’s Chris Kraemer on the power of patient impact
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- In 1 state, large hospitals dominate 340B's net savings
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
Brownstein Hyatt Farber Schreck (Wikipedia)
Their summary of the proposed federal budget is the best I found on a quick internet search. Please feel free to add others, especially more recent information.
I'll follow with an article on the importance of health policy in this election.
Biden Reveals Health Care Priorities in FY 2025 Budget
BROWNSTEIN CLIENT ALERT, MARCH 11, 2024
<clip>
A more detailed breakdown of the Department of Health and Human Services’ (HHS) budget request can be found here. The FY 2025 budget contains numerous health initiatives and priorities including:
- Reduces Drug and Other Health Care Costs for All Americans.
- Expands the IRA’s inflation rebates and $2,000 out-of-pocket prescription drug cost cap beyond Medicare and into the commercial market.
- Extends the $35 cost-sharing cap for a month’s supply of covered insulin products to the commercial market.
- Limits Medicare Part D cost-sharing for high-value generic drugs to no more than $2 for Medicare beneficiaries.
- Increases the pace of drug price negotiations by bringing more drugs into negotiation sooner after they launch.
- Authorizes HHS to negotiate supplemental drug rebates on behalf of interested states to pool purchasing power.
- Makes permanent the expanded Affordable Care Act (ACA) premium tax credits that were extended in the IRA.
- Provides Medicaid-like coverage to individuals in states that have not adopted Medicaid expansion, paired with financial incentives to ensure states maintain their existing expansions.
- Allows banning “facility fees” for telehealth and certain outpatient services in commercial insurance.
- Funds the continued implementation of the No Surprises Act.
- Honors America’s Commitment to Seniors and Americans in Need.
- Extends solvency of the Medicare Hospital Insurance (HI) trust fund indefinitely by ensuring high-income individuals pay their fair share.
- Proposes limiting the portion of Medicaid and CHIP managed care dollars spent on administration and incentivizing more investment in health care services by establishing a medical loss ratio.
- $150 billion over 10 years to improve and expand Medicaid home and community-based services (HCBS).
- Shifts funding for nursing home surveys from discretionary to mandatory beginning in 2026 and increases funding to cover 100% of statutorily mandated surveys.
- Proposes requiring greater transparency of nursing facility ownership and increasing the inspection of facilities with serious safety deficiencies.
- Invests in the Health and Well-Being of Families and the Next Generation.
- $390 million, a 36% increase above the 2023 enacted level, for the Title X Family Planning program to increase the number of patients served to 3.6 million.
- Transforms Behavioral Health Care.
- $1 billion to advance health information technology adoption and engagement in interoperability for certain behavioral health providers.
- Increases funding for the Children’s Mental Health Initiative by $50 million.
- Expands access to behavioral health services through investments in Certified Community Behavioral Health Clinics and Community Mental Health Centers.
- Doubles funding for the Mental Health Crisis Partnership Program.
- Invests in strengthening the behavioral health workforce, including integration into primary care settings.
- Proposes to extend incentive payment programs for Medicare providers in areas with clinician shortages to a broader set of clinicians, including behavioral health clinicians.
- Expands coverage of mental health benefits and strengthens the network of behavioral health providers in commercial insurance.
- Increases funding for the State Opioid Response grant program.
- Invests in a new technical assistance center to strengthen health providers’ understanding and treatment of substance use and women’s mental health.
- Invests in Medical Innovation, Scientific Breakthroughs and the Treatments of Tomorrow.
- $2 billion increase across the National Cancer Institute, Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and cancer projects at the Advanced Research Projects Agency for Health (ARPA-H).
- Additional mandatory funds for the Indian Health Service (IHS) beginning in 2026.
- Proposes creating a nationwide network of centers of excellence and innovation in women’s health.
- Doubles existing funding for the Office of Research on Women’s Health at the National Institutes of Health (NIH).
- Advances Health Equity.
- $376 million, an increase of $82 million above the 2023 enacted level, to support the ongoing implementation of the White House Blueprint for Addressing the Maternal Health Crisis.
- Expands Medicaid maternal health support services during the pregnancy and postpartum period by incentivizing states to reimburse a broad range of providers, including doulas, community health workers, peer support initiatives and nurse home visiting programs.
- $8 billion in discretionary resources in 2025, a 12% increase over the 2021 enacted level, for clinical services, preventative health, facilities construction, contract support costs and tribal leases at IHS.
- Proposes all IHS resources as mandatory beginning in 2026.
- Reauthorizes and increases funding for the Special Diabetes Program for Indians.
- Invests in direct primary care and mental health care services, expanded infrastructure and assistance for rural hospitals to remain open and provide high-quality services.
- Protects and Strengthens Public Health and Health Infrastructure.
- $2.5 billion in discretionary and mandatory funds over 10 years at CDC to support an evidence-based community violence initiative to address the causes of violence in communities and help reduce health inequities that characterize violence.
- $60 million for gun violence research across CDC and NIH.
- $9.8 billion in discretionary and mandatory funding for the Prevention and Public Health Fund, an increase of $499 million over the 2023 enacted level.
- $20 billion in mandatory funding for HHS public health agencies in support of the administration’s biodefense priorities as outlined in the 2022 National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.
- $75 million in the Administration for Strategic Preparedness and Response (ASPR) to manufacture more essential medicines, medical countermeasures and critical inputs in the United States.
- $12 million to strengthen FDA’s capacity to identify and address potential disruptions and shortage threats.
- Expands end-to-end supply chain visibility to priority FDA-designated essential medicines and devices to prepare for and mitigate potential shortages.
- Creates a new office to coordinate agency-wide activities on supply chain resilience and shortage mitigation efforts for drugs, biologics, medical devices and critical foods.
- Proposes a national program to significantly expand screening, testing, treatment, prevention and monitoring of hepatitis C infections in the United States.
- Proposes a new mandatory program to guarantee PrEP at no cost for all uninsured and underinsured individuals.
- Proposes a new Vaccines for Adults program to provide uninsured adults with access to routine and outbreak vaccines at no cost.
- Invests in protecting the health care system from cyber threats and includes funding for ASPR to coordinate cybersecurity efforts.
- $800 million to help high-need, low-resourced hospitals cover the upfront costs associated with implementing essential cybersecurity practices.
- $500 million for an incentive program to encourage all hospitals to invest in advanced cybersecurity practices.
- $141 million to continue strengthening HHS’s ability to protect and defend HHS systems and information, including $11 million to expand and enhance HHS’ capacity to protect the privacy and security of health information.
- Invests in HHS’ role in promoting the use of artificial intelligence (AI) in health care and public health while protecting against its risks.
As mentioned above, the president’s budget request starts the congressional budget and appropriations process. The budget presented by the Biden administration provides an aspirational roadmap to what the president would like to be implemented and how much Congress integrates these ideas into their own remains to be seen.
Followers of the MHF Forum and Michigan health policy will recognize many of these funds already leveraging policy in our state.
Joe Grogan has penned an avowedly partisan recapitulation of the ways Medicare funding has been looted to finance non medical programs in recent years:
The Honest Truth About Health Policy
As a frail President Biden walks onto the debate stage this week with the considerable challenge of defending a disastrous record on foreign policy, inflation, and border policies, he is certain to try to use healthcare as an area to score points against President Trump. The campaign is already airing ads on the subject. The media largely ignored or misrepresented Trump’s record on healthcare but there is one area that probably can’t be ignored any longer: Biden’s Medicare policies are hitting seniors hard.As he works to boost support from seniors, Biden has attempted to paint Trump as a threat to Medicare, but the truth is that Biden and the Democrats raided Medicare for green energy subsidies and America’s seniors are paying the price. In 2022, Democrats rammed through the Inflation Reduction Act (IRA) with major changes to Medicare’s prescription drug reimbursement—previously an area of bipartisanship—without a single Republican vote.
President Trump by contrast quietly pursued bipartisan changes, engaging with Senators Grassley and Wyden, Majority Leader McConnell and Speaker Pelosi for negotiations on a bipartisan drug pricing bill to help seniors manage drug costs and preserve the program, but that construct was tossed aside when Democrats took both legislative chambers and the White House and had the chance to implement drug price controls.
Much has been written about how Biden’s drug price setting scheme has led numerous developers to cancel research programs, and more cancellations are around the corner. But what has not gotten enough attention is that in a real feat of policy incompetence, cost savings for seniors are still years away, but seniors are already paying more for drug coverage. Plans requested an average premium increase of 21.5% for 2024 and requests will likely be elevated for 2025 as well. While Democrats included a cap on one factor used to determine beneficiary premiums, the cap does not extend to the premium as a whole. This, coupled with poorly designed changes to Medicare Part D’s structure triggered astronomical premium increases.
Part D instability will grow in 2025 and 2026 as the program’s price fixing provisions kick in and the rebates that keep premiums down disappear. Premiums will need to go up or benefit generosity will need to go down. Some plans may simply stop offering coverage in certain areas next year.
Why would Democrats destabilize the program and impose higher costs on seniors? A generous explanation might be that they didn’t think that this many drug development programs would get cancelled and they didn’t understand that the changes they were making to Part D’s structure would be catastrophic. But a more ideological explanation, and I think a more accurate one, is that Democrats just got greedy, which is ironic since this is their standard attack line against drug companies.
When President Trump proposed restructuring Part D to help seniors, all of the savings in drugs costs accrued to seniors and stayed in the Medicare program. But Democrats needed to loot Part D to pay for the green energy subsidies of the IRA.
Put another way, Biden cut benefits from people with a median income of $36,000 per year to subsidize cars purchased by individuals who earn five times as much. This $240 billion raid on Medicare would be shocking if they hadn’t done it before; Democrats cut $450 billion to $716 billion from Medicare to fund the Affordable Care Act.
When Republicans had both legislative houses and the White House under President Trump, we cut taxes. When Democrats had both houses under Obama and Biden, they raided Medicare to create new programs.
So, when Biden says Medicare won’t be cut on his watch, people should know he already did. Under Donald Trump; benefits were made more generous, particularly for Medicare Advantage enrollees, who Trump allowed to better manage their chronic conditions with enhanced benefits, such as home modifications to address disability. Ironically, the Biden Administration has spent the last three years squeezing Medicare Advantage and costing seniors more money. All the while, they have demonized for-profit companies in health care as they waged war against them.
For the first time in history Thursday night’s debate will feature two candidates who have both held the office defending their records, attacking the other’s. Biden’s team is hoping healthcare might provide a rare window to go on offense, but their actions while in office betray them. And by any objective measure, Trump’s record protecting Medicare is far better than the Biden record of looting it.
During the ACA/Obamacare debates, "Healthcare is 1/6 of the economy" became common knowledge.
Yes. They are connected.
In this timely debate prep, NBC refreshes our frame of reference.
Health care just as important as economy. What experts want Biden and Trump to address.
About half of U.S. adults say it is difficult to pay for their medical care. June 26, 2024, 11:03 AM EDTWhen President Joe Biden and former President Donald Trump face off Thursday during the first general election debate, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
Health care costs in the United States continue to rise — and Americans increasingly say they are unable to afford the care they need.
There is no issue in health care even remotely close to voter frustration over the high prices patients have to pay for medical care, said Drew Altman, president and CEO of KFF, a nonprofit group that researches health policy issues.
“People tend to think about health care as separate from the economy,” he said. “But when you talk to voters, it’s not separate at all in their heads. Health care is a dimension of their pocketbook economic concerns.”
National health care spending is projected to have increased 7.5% in 2023 to almost $4.8 trillion, faster than the projected growth of the overall economy, according to the Centers for Medicare and Medicaid Services.
The estimated health care spending per person — the average amount spent on health care services for each individual — reached $14,423 in 2023, up from $13,493 in 2022 and $13,012 in 2021.
The rising cost is hitting Americans’ wallets. About half of U.S. adults say it is difficult to afford their health care costs, according to a recent poll from KFF. About 1 in 4 say they — or a family member — had problems paying for health care in the past year.
That often means people will have to skip or delay the care that they need, said Dr. Adam Gaffney, a critical care physician at the Cambridge Health Alliance, who was not involved in the polling. A family member may try to provide financial aid, he added, but attempts to help another can sometimes aggravate problems for the entire family — most notably with medical debt.
"For American households, health care costs are one of the most important economic issues," he said. “What we spend on health care is going to be one of the biggest line items for a lot of families, particularly families with children or with elderly people with chronic diseases.”
No sweeping reform
Although Trump has revived threats to dismantle the Affordable Care Act, also known as Obamacare, major health care reform is unlikely to be a central issue during the debate, Altman said.
Biden is likely to tout the Inflation Reduction Act, which he signed into law in 2022.
Among the provisions is allowing Medicare, for the first time, to directly negotiate drug prices with pharmaceutical companies. Earlier this year, the government began negotiating prices on the 10 costliest prescription drugs covered by Medicare, which included heart medications and diabetes drugs. The government is expected to publish the new negotiated prices by Sept. 1.
Aside from Obamacare and abortion, Trump has provided little detail on what health care policy would look like in a potential second term. He made addressing the high cost of prescription drugs a tentpole of his previous term, including a push to allow states to import drugs from Canada and a rule that would tie prices for certain drugs to prices paid by countries overseas.
The greatest challenge for both Biden and Trump will be pitching health care cost policies that both sides of Congress can get behind, said Robin Feldman, a professor of law and director of the Center for Innovation at UC Law San Francisco.
“Notions of unity and compromise seem to be a distant memory in Congress, as they are in the nation,” she said.
”The idea of a big major sweeping reform has felt unlikely in recent years,” Gaffney said.
Breakthrough reforms remain challenging — but important.
“This distinction between health care as an issue and the economy as an issue at this point drives me crazy, because for real people, there is no distinction,” Altman said. “It’s one of their biggest economic concerns.”
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















